Search This Blog

Wednesday, September 26, 2018

Sarepta Therapeutics (SRPT) PT Raised to $200 at RBC


RBC Capital analyst Brian Abrahams raised the price target on Sarepta Therapeutics (NASDAQ: SRPT) to $200.00 (from $187.00)
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)